Independence Bank of Kentucky Invests $39,000 in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Independence Bank of Kentucky acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 4,200 shares of the pharmacy operator’s stock, valued at approximately $39,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in WBA. State Street Corp increased its holdings in shares of Walgreens Boots Alliance by 18.0% in the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after purchasing an additional 6,569,223 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after acquiring an additional 3,329,857 shares during the last quarter. Two Sigma Advisers LP purchased a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth $24,226,000. Thompson Siegel & Walmsley LLC boosted its position in shares of Walgreens Boots Alliance by 15.5% during the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock valued at $62,325,000 after acquiring an additional 934,754 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Walgreens Boots Alliance by 12.1% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock valued at $68,046,000 after purchasing an additional 817,762 shares during the period. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Bank of America boosted their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Morgan Stanley lowered their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research report on Friday, October 11th. TD Cowen reduced their target price on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, October 22nd. Truist Financial cut their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday. Finally, Royal Bank of Canada upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $13.19.

Walgreens Boots Alliance Price Performance

WBA stock opened at $10.28 on Monday. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $23.76. The firm has a market capitalization of $8.88 billion, a P/E ratio of -1.00, a P/E/G ratio of 1.41 and a beta of 0.64. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The business’s 50-day moving average is $10.12 and its two-hundred day moving average is $9.85.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the previous year, the business posted $0.66 EPS. The firm’s revenue was up 7.6% on a year-over-year basis. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.